• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Cosmetics
  • China cosmetics GMP inspections points have been finalised

China cosmetics GMP inspections points have been finalised

China cosmetics GMP inspections
Friday, 27 January 2023 / Published in Cosmetics, News, NMPA Registration in China

China cosmetics GMP inspections points have been finalised

China cosmetics GMP inspections points and judgment principles came into force on December 1, 2022. 

In advance of the Good Manufacturing Practice (GMP) being implemented on July 1, 2022, the NMPA issued a draft for comments of the Inspection Points and Judgment Principles. The final legislation came into force on December 1st last year (2022).

The inspection points are used to standardize supervision and inspection work by the NMPA but also to guide cosmetics registrants, cosmetics filers and cosmetics manufacturers in applying and assessing their own compliance with the GMP requirements.

These inspection points and judgment principles are part of the cascading legislation from the “Cosmetics Supervision and Administration Regulations (CSAR)” and “Measures of Cosmetics Manufacturing and Operation” and other regulations, rules and regulations,

In essence, the legislation contains a long list of criteria or inspection points that NMPA inspectors are looking for to determine compliance with the GMP.

This list can also be used by Registrants, Filers and Entrusted Manufacturers to undertake their own internal self-inspections and also to prepare for an NMPA inspection.

Inspections points

The compliance requirements are split into 3 levels of importance:

  • Critical items which are denoted by 2 asterisks
  • Key items which are denoted by 1 asterisk
  • And general items which have no asterisk.

The cosmetics inspection points are split into 2 annexes:

Annex One:

  • For production i.e. for the company actually undertaking the cosmetics production whether this is the entrusted manufacturer or the registrant or filer who manufacturers their own products.
  • There is a total of 81 inspection points of which:
    • 3 are critical items
    • 26 are key items
    • 52 are general items

Annex Two:

  • For commissioned or entrusted production whereby registrants and filers are inspected to ensure they have systems in place to verify the GMP compliance of their sub-contractor
  • There is a total of 24 inspection points of which:
    • 1 is a critical item
    • 8 are key items
    • 15 are general items.

If registrants and filers are engaged in both their own production and outsourced production then both lists apply i.e. a total of 105 inspection points.

But what is considered non-compliance?

  • Non-compliance is when you haven’t implemented the measures or systems to comply with the GMP requirements.
  • Defective compliance means you have established a system or procedure but it doesn’t comply fully and is therefore defective.

And depending on the mix of these items and the scoring system then you may fail the inspection and be in regulatory violation. This means you have committed a prohibited act of not complying with GMP provisions.

There are 3 main outcomes of the inspection:

  • Passed
  • Failed but the manufacturer is given the opportunity to rectify certain items within a given timeframe, after which the manufacturer is inspected again.
  • Failed due to serious issues or if a rectification report is not submitted on time or issues still remain then the inspection outcome will be a fail. In this instance any production license will be revoked. For importers this may mean that products may no longer be imported into the country.

Further information

Click here to read the China cosmetics GMP inspections points and judgment principles.

If you would like assistance in preparing for an NMPA Cosmetics GMP inspection, please contact us.

Click here to learn more about our cosmetics services.

GET IN TOUCH

🌐 Send us your enquiry
📚 Request our whitepapers
📣 Sign up for our newsletter

What you can read next

Real-World Evidence
Draft guidelines for Communication on Real-World Evidence (RWE) to support drug registration applications
China health food raw material technical requirements
China health food raw material technical requirements – Draft documents issued in July 2023
Cosmetics enterprises quality and safety responsibilities
Cosmetics enterprises quality and safety responsibilities – Draft regulation issued

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • laser therapy devices

    Clinical evaluation of laser therapy devices – New guidelines issued

    Clinical evaluation of laser therapy devices ha...
  • dental implant system

    Clinical evaluation of dental implant systems in China – New guidelines issued

    Clinical evaluation of dental implant system ha...
  • China Medical Device Webinar

    China Medical Device Webinar with AdvaMed Accel for U.S. exporters

    The China Medical Device Webinar will be featur...
  • webinar_medical-device-market-authorisation

    Cisema presenting at FORUM Institut: Medical device marketing authorisation for advanced – Masterclass China

    Cisema is delighted to hold a Masterclass with ...
  • generative AI services

    China’s generative AI interim measures now in effect

    China’s generative AI interim measures fo...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP